Product ID: SQMIG35H2172
Report ID:
SQMIG35H2172 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
124 |
Figures:
77
North America will dominate the global industry in 2022, accounting for over 40.75% of total sales. The region is predicted to maintain its leadership over the forecast period. A growing number of collaborations promoted by leading market participants to increase their R&D skills are expected to be responsible for this region's larger share. The major goal of the partnership was to create a unique interleukin-2 (IL-2) agonist designed to specifically boost regulatory T cell (Treg) proliferation for the treatment of autoimmune diseases.
The Asia Pacific area is predicted to expand at the fastest CAGR during the projection period due to the increasing incidence of cardiovascular illnesses, cancer, and autoimmune disorders in developing Asian countries. Furthermore, because of the rapid economic growth in developing nations such as India and China, untapped potential in this region is projected to add to the sector's growth. Furthermore, the presence of an important population base for study and clinical evaluation of protein applications in engineering is predicted to boost the region's expansion.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35H2172